Subpart B—Investigational New Drug Application (IND)
Sections
Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.
-
312.20
§ 312.20 Requirement for an IND. -
312.21
§ 312.21 Phases of an investigation. -
312.22
§ 312.22 General principles of the IND submission. -
312.23
§ 312.23 IND content and format. -
312.30
§ 312.30 Protocol amendments. -
312.31
§ 312.31 Information amendments. -
312.32
§ 312.32 IND safety reporting. -
312.33
§ 312.33 Annual reports. -
312.38
§ 312.38 Withdrawal of an IND.